71 related articles for article (PubMed ID: 33391943)
1. Racial Disparities in Malignant Primary Brain Tumor Survival in Texas From 1995 to 2013.
Ambe S; Lyon KA; Oh J; Rogers MKN; Olanipekun O; Basil NN; Fonkem E
Cureus; 2020 Nov; 12(11):e11710. PubMed ID: 33391943
[TBL] [Abstract][Full Text] [Related]
2. Incidence trends, rates, and ethnic variations of primary CNS tumors in Texas from 1995 to 2013.
Ambe SN; Lyon KA; Nizamutdinov D; Fonkem E
Neurooncol Pract; 2018 Aug; 5(3):154-160. PubMed ID: 30094045
[TBL] [Abstract][Full Text] [Related]
3. Health disparities and impact on outcomes in children with primary central nervous system solid tumors.
Austin MT; Hamilton E; Zebda D; Nguyen H; Eberth JM; Chang Y; Elting LS; Sandberg DI
J Neurosurg Pediatr; 2016 Nov; 18(5):585-593. PubMed ID: 27540957
[TBL] [Abstract][Full Text] [Related]
4. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in overall survival among renal cell carcinoma patients with young age and small tumors.
Schwartz K; Ruterbusch JJ; Colt JS; Miller DC; Chow WH; Purdue MP
Cancer Med; 2016 Feb; 5(2):200-8. PubMed ID: 26710924
[TBL] [Abstract][Full Text] [Related]
7. Investigation of racial differences in survival from non-small cell lung cancer with immunotherapy use: A Texas study.
Olateju OA; Zeng Z; Adenaiye OO; Varisco TJ; Zakeri M; Sujit SS
Front Oncol; 2022; 12():1092355. PubMed ID: 36698397
[TBL] [Abstract][Full Text] [Related]
8. Outcome disparities in colorectal cancer: a SEER-based comparative analysis of racial subgroups.
Al-Husseini MJ; Saad AM; Jazieh KA; Elmatboly AM; Rachid A; Gad MM; Ruhban IA; Hilal T
Int J Colorectal Dis; 2019 Feb; 34(2):285-292. PubMed ID: 30443675
[TBL] [Abstract][Full Text] [Related]
9. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States.
Xu L; Kim Y; Spolverato G; Gani F; Pawlik TM
Hepatobiliary Surg Nutr; 2016 Feb; 5(1):43-52. PubMed ID: 26904556
[TBL] [Abstract][Full Text] [Related]
11. Racial and socioeconomic disparities in malignant carcinoid cancer cause specific survival: analysis of the surveillance, epidemiology and end results national cancer registry.
Cheung R
Asian Pac J Cancer Prev; 2013; 14(12):7117-20. PubMed ID: 24460261
[TBL] [Abstract][Full Text] [Related]
12. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
Roche AM; Fedewa SA; Shi LL; Chen AY
Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in young-onset patients with colorectal, breast and testicular cancer.
Wu J; Ye J; Wu W; Fang D; Wang K; Yang L; Jiang X; Wang Q; Li L
J Cancer; 2019; 10(22):5388-5396. PubMed ID: 31632483
[No Abstract] [Full Text] [Related]
14. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
[TBL] [Abstract][Full Text] [Related]
15. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
16. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
17. Racial/ethnic disparities in the adjuvant chemotherapy of locally advanced colon cancer patients.
Zhong X; Guo Z; Gao P; Song Y; Sun J; Chen X; Sun Y; Wang Z
J Surg Res; 2018 Aug; 228():27-34. PubMed ID: 29907221
[TBL] [Abstract][Full Text] [Related]
18. Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011.
Malmgren JA; Calip GS; Atwood MK; Mayer M; Kaplan HG
Cancer; 2020 Jan; 126(2):390-399. PubMed ID: 31639221
[TBL] [Abstract][Full Text] [Related]
19. Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States.
Gaubatz ME; Bukatko AR; Simpson MC; Polednik KM; Adjei Boakye E; Varvares MA; Osazuwa-Peters N
Oral Oncol; 2019 Feb; 89():95-101. PubMed ID: 30732966
[TBL] [Abstract][Full Text] [Related]
20. Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database.
Ulanja MB; Rishi M; Beutler BD; Konam KG; Ambika S; Hinojosa T; Djankpa FT; Yang W; Gullapalli N
J Racial Ethn Health Disparities; 2019 Oct; 6(5):1035-1043. PubMed ID: 31215017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
